Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Total Non-Current Liabilities: 2018

Historic Total Non-Current Liabilities for Dianthus Therapeutics (DNTH) over the last 1 years, with Dec 2018 value amounting to $1.2 million.

  • Dianthus Therapeutics' Total Non-Current Liabilities was N/A to $1.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2018, which is N/A change from last year.
  • As of Q4 2018, Dianthus Therapeutics' Total Non-Current Liabilities stood at $1.2 million, which was up 15.37% from $1.1 million recorded in Q3 2018.
  • Dianthus Therapeutics' Total Non-Current Liabilities' 5-year high stood at $1.2 million during Q4 2018, with a 5-year trough of $796,000 in Q2 2018.
  • In the last 1 years, Dianthus Therapeutics' Total Non-Current Liabilities had a median value of $1.1 million in 2018 and averaged $1.0 million.